comparemela.com
Home
Live Updates
UCB to acquire Zogenix : comparemela.com
UCB to acquire Zogenix : comparemela.com
UCB to acquire Zogenix
/PRNewswire/ -- Regulated information – Inside information – UCB (Euronext: UCB) and Zogenix (NASDAQ: ZGNX) announced today that the companies have entered...
Related Keywords
Japan ,
California ,
United States ,
Emeryville ,
Brussels ,
Bruxelles Capitale ,
Belgium ,
Dravetc Dravet ,
Charl Van Zyl ,
Tevard Biosciences ,
Stephenj Farr ,
Twitter ,
Zogenix Inc ,
Barclays ,
Zinc Merger Sub Inc ,
Committee For Medicinal Products Human Use ,
National Institute Of Neurological Disorders ,
Neurology Head Of Europe International ,
Statement Of Zogenix Inc ,
Drug Administration ,
Latham Watkins ,
Lazard ,
Covington Burling ,
Exchange Commission ,
Zogenix Press ,
European Medicines Agency ,
Euronext ,
New Drug Application ,
Priority Review ,
Executive Vice President ,
International Markets ,
Chief Executive Officer ,
Zinc Merger Sub ,
Capital Markets Call ,
Prescribing Information ,
Boxed Warning ,
Euronext Brussels ,
Information About ,
Recommendation Statement ,
Information Agent ,
Looking Statement ,
Private Securities Litigation Reform Act ,
New Therapy ,
Medicinal Products ,
Human Use ,
Zogenix Submits New Drug Application ,
Epileptic Seizures Associated ,
Zogenix Pipeline ,
Zogenix Submits Type ,
Seizures Associated ,
Supplemental New Drug Application ,
Lennox Gastaut Syndrome ,
Core Dravet Syndrome ,
Med Child ,
Dravet Syndrome ,
National Institute ,
Neurological Disorders ,
Lennox Gastaut Syndrome Information ,
Last Accessed Jan ,
Fintepla Summary ,
Ucb And Zogenix ,
Health Care Amp Hospitals ,
Biotechnology ,
Medical Pharmaceuticals ,
Pharmaceuticals ,
Licensing ,
Acquisitions ,
Ergers And Takeovers ,